Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9168818rdf:typepubmed:Citationlld:pubmed
pubmed-article:9168818lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:9168818lifeskim:mentionsumls-concept:C0030940lld:lifeskim
pubmed-article:9168818lifeskim:mentionsumls-concept:C0332621lld:lifeskim
pubmed-article:9168818lifeskim:mentionsumls-concept:C2610925lld:lifeskim
pubmed-article:9168818lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9168818lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:9168818pubmed:issue2lld:pubmed
pubmed-article:9168818pubmed:dateCreated1997-6-23lld:pubmed
pubmed-article:9168818pubmed:abstractTextMouse thymocytes are known to undergo apoptosis by ligating some unique anti-Thy-1 monoclonal antibodies (mAbs), G7 and KT16. However, the precise mechanisms of Thy-1-mediated apoptosis are as yet unclear. We investigated Thy-1-mediated apoptosis using our previously generated anti-Thy-1 mAb, MCS-34, which was similar to G7 because both antibodies recognized both Thy-1.1 and Thy-1.2 and bound Thy-1A epitope. Unlike G7, MCS-34 alone could not induce apoptosis in thymocytes; however, it could induce apoptosis when it was cross-linked with second antibodies. Thus, MCS-34 could not aggregate by itself, but G7 could. In the course of investigating the apoptosis-related molecules that were involved in the thymocyte apoptosis induced by cross-linking of MCS-34 or by G7 ligation, we found that CPP 32-like proteases were activated during the apoptosis. Furthermore, the expression of bcl-2 and bcl-XL proteins was decreased in these apoptosis processes. Whereas the ligation of MCS-34 alone could not generate apoptosis signals that led to the activation of CPP32-like proteases and the decrease in bcl-2 and bcl-XL expression, the aggregation of Thy-1 glycoprotein might be crucial to signal thymocyte apoptosis. These results indicate that MCS-34 is a useful anti-Thy-1 mAb for analyzing the Thy-1-mediated signals since MCS-34 can control the level of apoptosis by using second antibodies.lld:pubmed
pubmed-article:9168818pubmed:languageenglld:pubmed
pubmed-article:9168818pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:citationSubsetIMlld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9168818pubmed:statusMEDLINElld:pubmed
pubmed-article:9168818pubmed:monthMaylld:pubmed
pubmed-article:9168818pubmed:issn0014-4827lld:pubmed
pubmed-article:9168818pubmed:authorpubmed-author:KatoYYlld:pubmed
pubmed-article:9168818pubmed:authorpubmed-author:LeeS HSHlld:pubmed
pubmed-article:9168818pubmed:authorpubmed-author:TsuruoTTlld:pubmed
pubmed-article:9168818pubmed:authorpubmed-author:KodamaNNlld:pubmed
pubmed-article:9168818pubmed:authorpubmed-author:FujitaNNlld:pubmed
pubmed-article:9168818pubmed:issnTypePrintlld:pubmed
pubmed-article:9168818pubmed:day1lld:pubmed
pubmed-article:9168818pubmed:volume232lld:pubmed
pubmed-article:9168818pubmed:ownerNLMlld:pubmed
pubmed-article:9168818pubmed:authorsCompleteYlld:pubmed
pubmed-article:9168818pubmed:pagination400-6lld:pubmed
pubmed-article:9168818pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:meshHeadingpubmed-meshheading:9168818-...lld:pubmed
pubmed-article:9168818pubmed:year1997lld:pubmed
pubmed-article:9168818pubmed:articleTitleAggregation of Thy-1 glycoprotein induces thymocyte apoptosis through activation of CPP32-like proteases.lld:pubmed
pubmed-article:9168818pubmed:affiliationInstitute of Molecular and Cellular Biosciences, University of Tokyo, Japan.lld:pubmed
pubmed-article:9168818pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9168818pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9168818pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:24832entrezgene:pubmedpubmed-article:9168818lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9168818lld:pubmed